
Servier is a global pharmaceutical group committed to therapeutic progress for a sustainable world.
We are a pharmaceutical group with a human dimension, international and independent, governed by a Foundation. Our model, unique, is our pride, but above all, it allows us to fully serve our vocation: Committed to therapeutic progress for the benefit of patients. Today, a global leader in cardiology, we have chosen to become a focused and innovative player in oncology by 2030, targeting difficult-to-treat cancers and dedicating more than 70% of our R&D budget to this area.
Servier is a global pharmaceutical group committed to therapeutic progress for a sustainable world.